Search Results
Nivolumab and salvage nivolumab plus ipilimumab for aRCC
Treatment-free survival results of nivolumab and salvage nivolumab + ipilimumab for accRCC
HCRN-GU16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced RCC
HCRN GU16-260: Nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients with adv...
Dr. Andre on Nivolumab Plus Ipilimumab in dMMR/MSI-H mCRC
David Quinn, MD, discusses Checkmate-214 investigating nivolumab + ipilimumab in aRCC patients
Nivolumab with ipilimumab for mRCC
Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
HCRN GU16-260: Nivolumab, Salvage Nivo/Ipi in Advanced Clear Cell RCC
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC
Nivolumab, ipilimumab and panitumumab in mCRC
Dr. Shoushtari on the Role of Nivolumab and Ipilimumab in Mucosal Melanoma
